AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glytime M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Xyris Life Sciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glytime M 1mg/500mg Tablet SR

Diabex Duo 1mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be limited due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests for complete blood count and liver function, are recommended.

Primary Ingredients of Glytime M 1mg/500mg Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glytime M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glytime M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glytime M 1mg/500mg Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

Common Side effects of Glytime M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glytime M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glytime M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Glytime M 1mg/500mg Tablet SR works:

Glytime M SR tablets (1mg/500mg) combine the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glytime M 1mg/500mg SR tablets with alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glytime M tablets (1mg/500mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against the risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Extended-release Glytime M tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glytime M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glytime M 1mg/500mg SR tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glytime M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low initial dose is typically prescribed for patients with mild to moderate liver disease; however, Glytime M 1mg/500mg SR tablets are unsuitable for those with severe hepatic dysfunction.

What if you forget to take Glytime M 1mg/500mg Tablet SR :

Should you forget a Glytime M 1mg/500mg SR tablet, take it immediately if you remember. However, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glytime M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glytime M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Glytime M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Glytime M 1mg/500mg Tablet SR and seek immediate medical attention.
Glytime M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glytime M 1mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach upset, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glytime M 1mg/500mg Tablet SR use can lead to Vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems – ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glytime M 1mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glytime M 1mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glytime M 1mg/500mg Table...
52
MRP 60
13% off